A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems. A urine test includes three parts namely, visual exam, microscopic exam, and dipstick test. Its primary aim is to screen health conditions. The urinalysis is carried out as routine medical checkup, pregnancy check-up, pre-surgery preparation, or on hospital admission to treat various disorders. It may be used to screen for and/or help diagnose conditions such as a kidney disorders, urinary tract infections, liver problems, diabetes or other metabolic conditions, to name a few. Additional tests and clinical valuation are often required to further examine findings of urinalysis and finally diagnose the causes or specific features of core problems. For example, urine infection is generally identified based on results of urinalysis. Urine culture is frequently ordered as a follow-up test to recognize the bacteria that may be causing the infection.
According to Centers for Disease Control and Prevention, as of 2016, around 4.9 million people in the U.S. are diagnosed with kidney disease. The major factors that are driving the growth of market are escalating prevalence of kidney diseases and urinary tract infections, technological advancements, increasing adoption rate of point-of-care urinalysis devices, implementation of Patient Protection and Affordable Care Act (PPACA), increasing healthcare expenditure and increasing senior citizen population.
Urinalysis Market Dynamics
According to Centers for Disease Control and Prevention (CDC), diabetes is one of the most common chronic diseases among humans, around 29.1 million people or 9.3% of the U.S population suffers from diabetes (2016). Increase in the prevalence of chronic diseases and geriatric population will give rise to prevention and cure for the chronic diseases, owing to the growth of urinalysis market. Emergence of portable and battery operated urinalysis devices and increase in implementation of urinalysis in emerging economic countries such as China, India and others, will create new opportunities for the urinalysis market. Integrated systems & urinalysis via smartphones and technological advancement present opportunities in the market.
North America is the largest region in the urinalysis market. The major driver for the large market share includes presence of key market players in the region such as Alere, Inc., Bio Rad, Siemens Healthcare, and Beckman Coulter. Moreover, introduction of the automated urine sediment analyzers such as digital flow morphology (digital imaging) & fluorescence flow cytometry together with high healthcare expenditure in this region. Asia Pacific is expected to observe the fastest growth during the forecast period. Increasing penetration rate of advanced urine analyzers, and the presence of local urine analyzer manufacturers, such as Mindray, Urit medical, and a large base of the target population with unmet clinical needs are expected to strengthen the market growth over the forecast period.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/382
Key players operating in the urinalysis market are Alere, Bio Rad, Roche Diagnostics, Mindray, Arkray, Inc., Sysmex, and Siemens Healthcare.